Alendronic acid
Also known as: Alendronate sodium
Active ingredient description
Alendronic acid is a bisphosphonate that inhibits osteoclastic bone resorption with no direct effect on bone formation. The bone formed during treatment with alendronic acid is of normal quality.
Medicine classification
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
Medicines
Alendronic acid is the active ingredient of these drugs:
Spain
Hong Kong
Brazil
Hong Kong
Hong Kong
Hong Kong
Hong Kong
Cyprus Germany Ireland Singapore United Kingdom
Brazil
Brazil
France Ireland Netherlands
Brazil
Tunisia
Australia
Brazil
Australia
Tunisia
Austria Brazil Canada France Germany
Ireland
Brazil
Cyprus
Singapore
Brazil
Hong Kong
Austria
Brazil
Lithuania
Brazil
Brazil
Brazil
Hong Kong
Ireland
Austria
Brazil
Hong Kong
Ireland
Spain
Spain
France
Germany Hong Kong Ireland
Alendronic acid is also found within below combination drugs:
ADROVANCE , ALENCALCI D3 , BENTEXO , BONENDRO , FONATPLUS , FOSALEN D3 , FOSAMAX D , FOSAMAX PLUS , FOSAVANCE , TEBONEVA , TRIDEPOS , VANTAVO
Product monographs
Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):
Structural formula
3D molecular structure
Unique ingredient identifier (UNII)
X1J18R4W8P - ALENDRONIC ACID
CAS registry number
121268-17-5 - Alendronate sodium trihydrate
66376-36-1 - alendronic acid
SNOMED-CT
391730008 - Alendronic acid (substance)